Bong-Seog Kim

机构：Boryung Pharma (South Korea)

发表论文 67 篇 · 总被引 808 次 · h-index 13

代表论文

• Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non–Small-Cell Lung Cancer Harboring ROS1 Rearrangement (2017 · Journal of Clinical Oncology · 被引 298)
• Pazopanib maintenance after first-line etoposide and platinum chemotherapy in patients with extensive disease small-cell lung cancer: a multicentre, randomised, placebo-controlled Phase II study (KCSG-LU12-07) (2018 · British Journal of Cancer · 被引 42)
• The impact of primary tumor location in patients with metastatic colorectal cancer: a Korean Cancer Study Group CO12-04 study (2017 · The Korean Journal of Internal Medicine · 被引 34)
• Perspectives on Professional Burnout and Occupational Stress among Medical Oncologists: A Cross-sectional Survey by Korean Society for Medical Oncology (KSMO) (2020 · Cancer Research and Treatment · 被引 19)
• Prediction of Two-Year Recurrence-Free Survival in Operable NSCLC Patients Using Radiomic Features from Intra- and Size-Variant Peri-Tumoral Regions on Chest CT Images (2022 · Diagnostics · 被引 17)
• Interference with daily functioning by breakthrough pain in patients with cancer (2020 · Supportive Care in Cancer · 被引 12)